An expression of T-lymphocyte subset phenotype postrenal transplantation: feasibility for tailored individualized immunosuppressive therapy.
Jun
Q
Q
Department of Urology, Changzheng Hospital, Shanghai, China. jasonqi@public7.sta.net.cn
Li
Yushan
L
L
Ming
Z
Z
Zhilian
M
M
D000328:Adult; D000367:Age Factors; D000368:Aged; D015703:Antigens, CD / Q000097:blood*; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D016130:Immunophenotyping; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000145:classification / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000097:blood
D015703:Antigens, CD; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D016212:Transforming Growth Factor beta; D003404:Creatinine